info@tajpharma.com +91 84484 44095 / 8071 555 357
Vapi, Gujarat, India WHO-GMP Certified

Manufacturing Excellence

State-of-the-Art Facilities | WHO-GMP Certified | Quality Assured

Our Manufacturing Facility

Taj Pharma operates a state-of-the-art manufacturing facility in Vapi, Gujarat, dedicated to producing high-quality Dolutegravir tablets. Our facility is equipped with the latest pharmaceutical manufacturing technology and infrastructure, ensuring consistent product quality and regulatory compliance.

We maintain strict adherence to WHO-GMP and EU-GMP standards with continuous investment in facility upgrades and equipment modernization to meet the growing demand for quality pharmaceutical products.

Manufacturing Facility Overview

Manufacturing Plant Overview

Plant Overview: State-of-the-art facility in Vapi, Gujarat

Production Line

Production Line: Advanced tablet compression & packaging

Quality Control Lab

QC Laboratory: Advanced testing & analysis equipment

Quality Assurance

Quality Assurance: Rigorous testing & verification

Manufacturing Capabilities & Specifications

Capability Details
Annual Production Capacity 500+ million tablets per annum
Product Range TAPIVIR 50 (50mg), TAPIVIR DT 10 (10mg Dispersible)
Packaging Options Blister packs (10x10), bottles (30/60/100 tabs), bulk containers
Lead Time 30-45 days for standard orders; 15-20 days for urgent
Quality Standards USP, BP, IP, EP, WHO compliant
Export Capability Approved for 50+ countries worldwide
Shelf Life 24 months (under proper storage conditions)
Storage Conditions 15-30°C, protected from light & moisture

Facility Specifications & Infrastructure

Building Infrastructure
  • Built-up Area: 50,000+ sq. meters
  • Manufacturing Area: 15,000 sq. meters
  • Quality Control Lab: 2,500 sq. meters
  • Warehouse: 10,000 sq. meters
  • Clean Rooms: ISO Class 7 & 8
Utilities & Systems
  • Power Supply: 500 KVA with backup generators
  • Water System: RO + DM water generation (50,000 L/day)
  • HVAC System: Advanced filtration with 15 air changes/hour
  • Temperature Control: ±2°C precision
  • Humidity Control: 45-55% RH maintained

Manufacturing Process

Our Dolutegravir manufacturing process follows strict pharmaceutical standards with 6 key stages:

1
Raw Material Selection

High-purity pharmaceutical-grade materials from certified suppliers

2
Formulation & Blending

Precise mixing in controlled environment

3
Tablet Compression

Advanced machines ensure uniform quality

4
Quality Testing

Comprehensive testing and analysis

5
Packaging

Blister and bottle packaging with tamper-evident features

6
Final Release

Quality approval before distribution

Equipment & Infrastructure

Manufacturing Equipment
  • ✓ High-speed tablet compression machines
  • ✓ Blister packing machines
  • ✓ Bottle filling and capping equipment
  • ✓ Labeling and serialization systems
  • ✓ Vision inspection systems
Facility Features
  • ✓ ISO Class 7 clean rooms
  • ✓ Temperature & humidity control
  • ✓ HVAC filtration systems
  • ✓ Purified water systems
  • ✓ Waste management systems

Quality Assurance & Testing

Every batch of Dolutegravir tablets undergoes rigorous quality testing:

  • HPLC Assay Analysis: Precise determination of active ingredient content
  • Dissolution Testing: Bioavailability assessment
  • Microbial Testing: Sterility and contamination checks
  • Stability Testing: Long-term storage evaluation
  • Physical Testing: Hardness, friability, weight variation
Manufacturing Facility

State-of-the-art facility in Vapi, Gujarat with WHO-GMP and EU-GMP certification.

Location: Vapi, Gujarat, India
Inquiries

For manufacturing inquiries and bulk orders, contact our team.

Contact Us

Related Information

Explore more about our products and services

View Products

Browse our complete range of Dolutegravir tablets and pharmaceutical products.

View All
Get Quote

Request a competitive quote for your bulk orders with flexible payment terms.

Request Quote
FAQ

Find answers to frequently asked questions about our products and services.

View FAQ
Blog

Read articles about HIV treatment, Dolutegravir, and pharmaceutical industry updates.

Read Blog